| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
49,184 |
36,539 |
$3.64M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,749 |
1,619 |
$134K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,005 |
1,850 |
$129K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
10,731 |
9,221 |
$117K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
912 |
845 |
$104K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,230 |
1,058 |
$86K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,079 |
1,035 |
$83K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
755 |
699 |
$63K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,135 |
4,564 |
$48K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
3,021 |
2,711 |
$41K |
| 95117 |
|
4,889 |
1,844 |
$33K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,578 |
2,006 |
$27K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,371 |
1,169 |
$20K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
330 |
296 |
$16K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
342 |
308 |
$11K |
| 92551 |
|
1,478 |
1,342 |
$11K |
| 90474 |
|
636 |
613 |
$6K |
| 95115 |
|
1,315 |
351 |
$5K |
| 90670 |
|
1,214 |
1,169 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
104 |
102 |
$4K |
| 99173 |
|
1,993 |
1,822 |
$4K |
| 0071A |
|
115 |
95 |
$3K |
| 0002A |
|
91 |
87 |
$3K |
| 0001A |
|
111 |
104 |
$3K |
| 81002 |
|
1,060 |
912 |
$2K |
| 0072A |
|
72 |
72 |
$2K |
| 87807 |
|
212 |
191 |
$2K |
| 90651 |
|
284 |
245 |
$2K |
| 85018 |
|
983 |
899 |
$1K |
| 90649 |
|
124 |
94 |
$1K |
| D1206 |
Topical application of fluoride varnish |
79 |
60 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
265 |
251 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
696 |
576 |
$557.83 |
| 90707 |
|
119 |
118 |
$417.00 |
| 90715 |
|
330 |
274 |
$342.49 |
| 86308 |
|
75 |
55 |
$309.78 |
| 90656 |
|
533 |
461 |
$211.48 |
| 90671 |
|
185 |
94 |
$200.00 |
| 90473 |
|
22 |
19 |
$181.72 |
| 90647 |
|
340 |
332 |
$154.19 |
| 90716 |
|
42 |
42 |
$105.45 |
| 90734 |
|
376 |
307 |
$76.00 |
| 96127 |
|
20 |
19 |
$62.01 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
424 |
377 |
$51.23 |
| 90633 |
|
551 |
520 |
$0.00 |
| 91300 |
|
84 |
81 |
$0.00 |
| 90710 |
|
114 |
95 |
$0.00 |
| 90672 |
|
24 |
21 |
$0.00 |
| 90723 |
|
746 |
729 |
$0.00 |
| 90680 |
|
594 |
586 |
$0.00 |
| 91307 |
|
92 |
88 |
$0.00 |
| 90698 |
|
13 |
13 |
$0.00 |
| 90696 |
|
145 |
128 |
$0.00 |
| 90697 |
|
138 |
66 |
$0.00 |
| 90686 |
|
36 |
35 |
$0.00 |